Alexion Pharmaceuticals, Inc. · 5 days ago
Associate Director- Portfolio Contract Strategy, CVRM
Alexion Pharmaceuticals, Inc. is focused on turning ideas into life-changing medicines. The Associate Director of Portfolio Contract Strategy will develop and implement contract strategies for key Market Access customers, working closely with account teams and internal collaborators to optimize pricing and access objectives.
BiotechnologyHealth CareMedicalTherapeutics
Responsibilities
Assist in the development of contract strategies and brings them through the approval/governance process
Directly partners with customer facing teams around prioritized key initiatives
Co-development and execution of negotiation strategies
Coordinate with team of analysts/specialists in operational activities such as rebates, chargebacks, government reporting, contract writing and process approvals
Monitors environment for shifts in trends or behaviors, interpret likely impact and suggest appropriate actions around life cycle contracting and pricing considerations
Develops deep understanding of competitive market conditions that affect pricing for individual brands, therapeutic areas and overall industry
Serves as a resource for Licensing and Business Development in assessing pricing on potential opportunities
Qualification
Required
Bachelor's degree; preferably in a relevant field (Marketing, Science, Economics or Finance)
3 years experience in the pharmaceutical or healthcare industry
Understanding of Market Access and Healthcare delivery systems
Analytical skills including problem solving, forecasting, contract development and financial modeling
Demonstrated negotiation & relationship building skills
Solution/Innovation mindset
Preferred
MBA/JD
Understanding of healthcare marketing and sales practices
Thorough understanding of pharmaceutical manufacturing business models with specific knowledge of brand team operation, brand planning and sales
Finance and/or analytics background
Contract development and negotiation experience
Clinical Acumen/Health Economics
Company
Alexion Pharmaceuticals, Inc.
Alexion, AstraZeneca Rare Disease is focused on pioneering new possibilities for the rare disease community.
H1B Sponsorship
Alexion Pharmaceuticals, Inc. has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (49)
2024 (57)
2023 (51)
2022 (29)
2021 (27)
2020 (17)
Funding
Current Stage
Public CompanyTotal Funding
$5.8M2020-12-12Acquired
1999-02-12Post Ipo Equity· $5.8M
1996-02-29IPO
Leadership Team
Recent News
bloomberglaw.com
2025-12-20
Company data provided by crunchbase